EN
News Releases

News Releases

Headlines

Anhui Double-Crane’s Metronidazole and Sodium Chloride Injection Passed the Consistency Evaluation of Quality and Efficacy of Generic Drugs

Anhui Double-Crane’s Metronidazole and Sodium Chloride Injection Passed the...

CR Double-Crane announced on January 22nd that its wholly-owned subsidiary Double-Crane Pharmaceutical (Anhui) received the Approval Document from the National Medical Products Administration (“NMPA”) on Drug Supplementary Applica...
CR Double-Crane announced on January 22nd that its wholly-owned subsidiary Double-Crane Pharmaceutical (Anhui) received the Approv...

Detailed>>

Detailed +

2021.06

2021.06.04

Runsheng’s ANDA application to FDA for Advair Diskus Generic Grug was given “Priority Review”

Runsheng’s ANDA application to FDA for Advair Diskus Generic Grug was given...

Runsheng’s ANDA application to FDA for Advair Diskus Generic Grug was given “Priority Review”

Runsheng’s ANDA application to FDA for Advair Diskus Generic Grug was given “Priority Review”

2021.05

2021.05.20

CR Biopharmaceutical and Hybio Pharmaceutical signed a cooperation agreement

CR Biopharmaceutical and Hybio Pharmaceutical signed a cooperation agreemen...

CR Biopharmaceutical and Hybio Pharmaceutical signed a cooperation agreement

CR Biopharmaceutical and Hybio Pharmaceutical signed a cooperation agreement

2021.03

2021.03.31

CR Sanjiu cooperate with Ryukakusan to protect throat health in China

CR Sanjiu cooperate with Ryukakusan to protect throat health in China

CR Sanjiu joins hands with Ryukakusan to protect throat health in China

CR Sanjiu joins hands with Ryukakusan to protect throat health in China

2020.12

2020.12.23

CR Double-Crane acquired 38.7% interest of Dongying Tiandong Pharmaceutical Co., Ltd.’s

CR Double-Crane acquired 38.7% interest of Dongying Tiandong Pharmaceutical...

On December 22, 2020, the signing ceremony between CR Double-Crane and Shandong Haike was held in Dongying, Shandong, and the “Dongying Tiandong Pharmaceutical Equity Transfer Agreement” was formally signed.

On December 22, 2020, the signing ceremony between CR Double-Crane and Shandong Haike was held in Dongying, Shandong, and the “Don...

2020.12

2020.12.14

NIP Pharm received the clinical trial approval of innovative drug NIP046

NIP Pharm received the clinical trial approval of innovative drug NIP046

On December 9, the innovative drug research and development platform of CR Pharm, NIP Pharm, received the "Notice of Drug Clinical Trial Approval" issued by the National Medical Products Administration (NMPA), approving NIP046 tablets for rheumatoid arthritis adaptation Clinical trials.

On December 9, the innovative drug research and development platform of CR Pharm, NIP Pharm, received the "Notice of Drug Clinical...
Prev 1 2 3 ... 5 Next
Back to Top